Literature DB >> 16695250

THE TREATMENT OF LOBAR PNEUMONIA WITH PENICILLIN.

W S Tillett1, J E McCormack, M J Cambier.   

Abstract

Entities:  

Year:  1945        PMID: 16695250      PMCID: PMC435492          DOI: 10.1172/JCI101640

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  THE USE OF PENICILLIN IN THE LOCAL TREATMENT OF PNEUMOCOCCAL EMPYEMA.

Authors:  W S Tillett; J E McCormack; M J Cambier
Journal:  J Clin Invest       Date:  1945-07       Impact factor: 14.808

2.  SULFONAMIDE-FAST PNEUMOCOCCI. A CLINICAL REPORT OF TWO CASES OF PNEUMONIA TOGETHER WITH EXPERIMENTAL STUDIES ON THE EFFECTIVENESS OF PENICILLIN AND TYROTHRICIN AGAINST SULFONAMIDE-RESISTANT STRAINS.

Authors:  W S Tillett; M J Cambier; W H Harris
Journal:  J Clin Invest       Date:  1943-03       Impact factor: 14.808

  2 in total
  5 in total

1.  Interactions of host, microbe and chemotherapeutic agent.

Authors:  C M MACLEOD
Journal:  Bull N Y Acad Med       Date:  1955-06

2.  THE COMPARATIVE EFFECTS OF CONTINUOUS AND INTERMITTENT PENICILLIN THERAPY ON THE FORMATION OF ANTISTREPTOLYSIN IN HEMOLYTIC STREPTOCOCCAL PHARYNGITIS.

Authors:  E D Kilbourne; J P Loge
Journal:  J Clin Invest       Date:  1948-07       Impact factor: 14.808

3.  A comparison of intramuscular and oral penicillin in penumococcic pneumonia.

Authors:  W W G MACLACHLAN; M M BRACKEN
Journal:  Can Med Assoc J       Date:  1949-08       Impact factor: 8.262

4.  The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  J Bacteriol       Date:  1950-05       Impact factor: 3.490

5.  STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : II. THE EFFECT OF SULFONAMIDE THERAPY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA.

Authors:  W B Wood; E N Irons
Journal:  J Exp Med       Date:  1946-09-30       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.